BVXV Annual Total Assets
$27.07 M
-$4.97 M-15.51%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual total assets is $27.07 million, with the most recent change of -$4.97 million (-15.51%) on December 31, 2022. During the last 3 years, it has fallen by -$6.36 million (-19.03%).BVXV Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Total Assets
$19.90 M
-$3.40 M-14.58%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly total assets is $19.90 million, with the most recent change of -$3.40 million (-14.58%) on June 30, 2023. Over the past year, it has dropped by -$4.75 million (-19.27%).BVXV Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Total Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -15.5% | -19.3% |
3 y3 years | -19.0% | -20.0% |
5 y5 years | +15.2% | +19.6% |
BVXV Total Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -19.0% | -41.9% |
BiondVax Pharmaceuticals Total Assets History
Date | Annual | Quarterly |
---|---|---|
June 2023 | - | $19.90 M(-14.6%) |
Mar 2023 | - | $23.29 M(-13.9%) |
Dec 2022 | $27.07 M(-15.5%) | $27.07 M(+29.1%) |
Sept 2022 | - | $20.96 M(-14.9%) |
June 2022 | - | $24.65 M(-17.9%) |
Mar 2022 | - | $30.03 M(-6.2%) |
Dec 2021 | $32.04 M(+81.0%) | $32.04 M(+27.3%) |
Sept 2021 | - | $25.16 M(-7.0%) |
June 2021 | - | $27.04 M(-4.7%) |
Mar 2021 | - | $28.37 M(+60.3%) |
Dec 2020 | $17.70 M(-47.1%) | $17.70 M(-18.5%) |
Sept 2020 | - | $21.73 M(-12.6%) |
June 2020 | - | $24.86 M(-25.6%) |
Dec 2019 | $33.43 M(+18.9%) | $33.43 M(-2.4%) |
Sept 2019 | - | $34.26 M(+61.6%) |
June 2019 | - | $21.20 M(-22.6%) |
Mar 2019 | - | $27.39 M(-2.5%) |
Dec 2018 | $28.10 M | $28.10 M(+25.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | $22.36 M(+34.4%) |
June 2018 | - | $16.64 M(-18.9%) |
Mar 2018 | - | $20.52 M(-12.7%) |
Dec 2017 | $23.51 M(+200.3%) | $23.51 M(-0.9%) |
Sept 2017 | - | $23.71 M(+101.0%) |
June 2017 | - | $11.80 M(+2.8%) |
Mar 2017 | - | $11.48 M(+46.6%) |
Dec 2016 | $7.83 M(-26.0%) | $7.83 M(-9.2%) |
Sept 2016 | - | $8.62 M(-7.9%) |
June 2016 | - | $9.36 M(-7.8%) |
Mar 2016 | - | $10.15 M(-4.1%) |
Dec 2015 | $10.58 M(+123.2%) | $10.58 M(-7.1%) |
Sept 2015 | - | $11.39 M(-5.2%) |
June 2015 | - | $12.02 M(+190.5%) |
Mar 2015 | - | $4.14 M(-12.7%) |
Dec 2014 | $4.74 M(-36.1%) | $4.74 M(-11.8%) |
Sept 2014 | - | $5.38 M(-27.5%) |
Dec 2013 | $7.42 M(+19.3%) | $7.42 M |
Dec 2012 | $6.22 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual total assets?
- What is the all time high annual total assets for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual total assets year-on-year change?
- What is BiondVax Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly total assets year-on-year change?
What is BiondVax Pharmaceuticals annual total assets?
The current annual total assets of BVXV is $27.07 M
What is the all time high annual total assets for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual total assets is $33.43 M
What is BiondVax Pharmaceuticals annual total assets year-on-year change?
Over the past year, BVXV annual total assets has changed by -$4.97 M (-15.51%)
What is BiondVax Pharmaceuticals quarterly total assets?
The current quarterly total assets of BVXV is $19.90 M
What is the all time high quarterly total assets for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly total assets is $34.26 M
What is BiondVax Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, BVXV quarterly total assets has changed by -$4.75 M (-19.27%)